• Drypowder
  • Posts
  • This Week's Venture Capital Funds

This Week's Venture Capital Funds

Thomvest Ventures, Act One Ventures, Cardumen Capital, Mirae Asset Capital, Sandwater

Where’s that money? 💸

Thomvest Venture Partners

Global | Early Stage | Fintech

Thomvest Ventures, a Bay Area venture capital firm, has announced a new $250 million fund and the promotion of Umesh Padval and Nima Wedlake to managing directors. The firm was founded about 25 years ago by Peter Thomson, a majority owner of Thomson Reuters, with a focus on financial and real estate technology, cybersecurity, cloud, and AI/data infrastructure.

The new fund brings the firm's total AUM to $750 million. Thomvest Ventures expects to invest in 25 to 30 companies from the new fund, with check sizes ranging from $5 million to $15 million.

Act One Ventures

Global | Seed | Software

Act One Ventures, a Los Angeles-based early-stage venture capital firm, has successfully raised $73 million for its third fund. The firm is led by General Partners Alejandro Guerrero and Michael Silton who will continue backing seed stage companies focusing on vertical SaaS, fintech, compliance, and ecommerce infrastructure. Act One Ventures has invested in a total of 47 companies since its inception in 2016.

Cardumen Capital

Europe and Israel | Pre-seed and Seed | Deep Tech

Cardumen Capital, an Israeli-European venture capital firm, has successfully raised $120 million for its second deep tech fund. The fund focuses on pre-seed and seed stage investments in fields such as AI, Cybersecurity, Big Data, and Information Technologies.

The firm was founded in 2018 by leading venture capitalists Gonzalo Martínez de Azagra and Igor de la Sota with offices in Tel Aviv and Madrid.

Naveen M. Krishnan, Managing Director of Mirae Asset Capital

Global | Seed to Growth | Life Sciences

Mirae Asset Capital Life Science has officially launched its inaugural $50 million fund. The core sectors of interest include oncology, immunology, cardiovascular/metabolic disease, CNS/ophthalmology, and genetic disease.

Naveen M. Krishnan is the Managing Director of Mirae Asset Capital Life Science and oversees the firm's investments, strategy, and growth.

Sandwater Partners

Europe | Seed and Series A | Climate and Health

Sandwater has successfully closed its early-stage venture fund at 1.4 billion NOK (~130M USD), doubling its target. The Norwegian fund focuses on early-stage companies addressing global challenges in climate, energy, and healthcare.

As a thematic investor with a strong impact mandate, Sandwater focuses on four verticals of Resource Efficiency, Energy Transition, Impact Enablers, and Health.

Who’s Hiring? 😎

Psst…firms expanding their investment team are often raising a new fund behind the scenes. 💰

Early stage software, Europe

Analyst | Berlin, Germany | Application

B2B software

Associate | London, England | Application

Deep Tech

Senior Associate | Palo Alto, CA | Application

Health and Wellness, Future of Work, Fintech, Sustainability

Summer Associate | Los Angeles, CA | Application

Sector Agnostic

Associate | New York City, NY | Application

Edtech

Associate | Austin, TX | Application

Enterprise VC

Associate | San Francisco, CA | Application

Firms that raised capital in the past few weeks.

January 15th- Venrock, Exponent Founders Capital, Seedstars…

January 9th- Baird Capital, Artis Ventures, Partech…

December 18th- Box Group, Cyber Fund, Singular…

December 11th- Collateral Good, BioStar Capital, Intuitive Ventures…

November 29th- NXTP, Twelve Below, Calm Ventures…

To get your company in front of thousands of entrepreneurs and venture capitalists, reply to this email about your interest in sponsoring the newsletter.

If you know someone who might benefit from these updates, share this link so they can sign up! 👇😊

Cheers! 🥂 Have a great week.

Reply

or to participate.